El Paso Medical, LLC

El Paso Medical, LLC specializes in lacrimal punctum plugs, which are designed to address excessive tearing by blocking the drainage system of the eye. Their primary product, the Quintess Tear Pool, is a silicone-based plug inserted into the lacrimal punctum to help relieve symptoms of epiphora (watery eyes).

El Paso Medical, LLC is headquartered in the United States. The company’s location is relevant for regulatory purposes, as it influences compliance requirements and reporting standards for its devices.

El Paso Medical, LLC’s lacrimal punctum plugs, including the Quintess Tear Pool, are classified as Class II devices under FDA regulations. This classification is based on the risk associated with the device’s intended use, requiring special controls beyond general controls to ensure safety and effectiveness.

Yes, El Paso Medical, LLC’s devices are included in the FDA’s Unique Device Identifier (UDI) database. This registry helps track and identify medical devices for regulatory, clinical, and market surveillance purposes, ensuring transparency and traceability in the healthcare system.

The Quintess Tear Pool is designed to manage chronic epiphora (excessive tearing) by occluding the lacrimal punctum. By blocking the natural drainage pathway, it reduces fluid overflow from the eye, providing symptomatic relief for patients with conditions like blocked tear ducts or excessive lacrimation.